Daria Sohel, Islam Md Rabiul
Department of Pharmacy, University of Asia Pacific, Farmgate, Dhaka, Bangladesh.
Clin Pathol. 2022 May 18;15:2632010X221099889. doi: 10.1177/2632010X221099889. eCollection 2022 Jan-Dec.
The COVID-19 pandemic has put enormous strain on the global public health and healthcare systems. Here we aimed to assess the prevalence and impact of indiscriminate use of antibiotics for COVID-19 treatment in south Asian countries. We observed the indiscriminate use of antibiotics in south Asian countries and other similar parts of the world. Along with vaccines, people in poor and developing countries have been taking antibiotics and some other medications without proper jurisdiction during the waves of the COVID-19 pandemic. We all know that COVID-19 is a viral disease, and only a few patients might have bacterial co-infections. Therefore, the role of antibiotics is ambiguous in most COVID-19 cases. Consequently, the overuse of antibiotics would cause antimicrobial resistance that has the potential to become a 2-edged sword after the COVID-19 pandemic era. Our findings emphasize the judicious use of antibiotics in COVID-19 therapy, especially in poor and developing countries across the globe.
新冠疫情给全球公共卫生和医疗体系带来了巨大压力。在此,我们旨在评估南亚国家在新冠治疗中滥用抗生素的流行情况及其影响。我们观察到南亚国家以及世界其他类似地区存在抗生素滥用现象。在新冠疫情期间,除了疫苗之外,贫困和发展中国家的人们在没有适当监管的情况下服用抗生素及其他一些药物。我们都知道,新冠是一种病毒性疾病,只有少数患者可能会合并细菌感染。因此,在大多数新冠病例中,抗生素的作用并不明确。所以,抗生素的过度使用会导致抗菌药物耐药性,这在新冠疫情时代之后有可能成为一把双刃剑。我们的研究结果强调在新冠治疗中应谨慎使用抗生素,尤其是在全球的贫困和发展中国家。